Q3 FY2025 · Press release
Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease · November 19, 2025 · 4 pages
Read Agios Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional